USC Norris Comprehensive Cancer Center
August 4, 2020
By Alison Rainey
Keck Medicine of USC has named renowned oncologist and cancer researcher Steven Grossman, MD, PhD, as USC Norris Comprehensive Cancer Center’s cancer physician in chief. He will step into the role on Sept. 15.
In this inaugural position, Grossman will provide executive leadership for oncology services, partnering with academic and clinical leaders to advance new models of multidisciplinary care delivery. He will also serve as a professor of medicine at the Keck School of Medicine of USC.
Grossman, an internationally recognized expert in gastrointestinal cancers, is a past recipient of a Research Scholar award from the American Cancer Society, the Kimmel Scholar award from the Sidney Kimmel Foundation and a Howard Temin Award from the National Cancer Institute.
He previously served as the deputy director and Dianne Nunnally Hoppes Endowed Chair in Cancer Research at Virginia Commonwealth University Massey Cancer Center, as well as the chair of the division of hematology, oncology and palliative care.
“We are thrilled that Dr. Grossman will join us,” said Caryn Lerman, PhD, director of USC Norris and associate dean for cancer programs at the Keck School. “His exceptional experience and track record as a clinical and scientific leader will enable us to accelerate our mission of delivering the most innovative, evidence-based care to our diverse patient population.”
Grossman received his undergraduate degree from Princeton University and his medical and doctoral degrees from the University of Chicago. He completed a residency in internal medicine at the Harvard Medical School-affiliated Brigham and Women’s Hospital and completed a fellowship in medical oncology and postdoctoral research training at the Dana-Farber Cancer Institute.
“I am truly honored to join USC Norris in this newly created position,” Grossman said. “I am excited to expand USC Norris’ exceptional patient-focused clinical cancer services that provide multidisciplinary care and integrate cutting-edge clinical research at every level of the patient experience.”